Colorado
CNS clinical trials in Colorado
89 CNS studies are recruiting participants at sites in 12 cities across Colorado as of November 16, 2026, according to ClinicalTrials.gov.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Every Colorado city with a recruiting study
By research area: Depression (30), Parkinson's Disease (20), Multiple Sclerosis (14), Migraine (11), Epilepsy (9), Schizophrenia (3), ADHD (2).
Aurora (54), Denver (16), Colorado Springs (11), Fort Collins (8), Centennial (4), Englewood (4), Grand Junction (4), Boulder (2), Edwards (2), Basalt (1), Greeley (1), Westminster (1).
The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.
Depression: recently updated in Colorado
Basic details from each study's public record (the 12 most recently updated of 89). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder
- Phase 2
- Ages 18 to 70
- All sexes
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Recruiting in
- Denver
- Registry record
- NCT07226661 · updated
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Phase 2
- Ages 18 to 80
- All sexes
- Sponsor
- Reunion Neuroscience Inc
- Recruiting in
- Aurora
- Registry record
- NCT07002034 · updated
Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Colorado on ClinicalTrials.gov.
Schizophrenia: recently updated in Colorado
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Phase 2
- Ages 55 to 90
- All sexes
- Sponsor
- MapLight Therapeutics
- Recruiting in
- Denver
- Registry record
- NCT06887192 · updated
Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in Colorado on ClinicalTrials.gov.
Parkinson's disease: recently updated in Colorado
Neocortical Microarchitecture of Executive Function
- No phase
- Ages 45 to 85
- All sexes
- Sponsor
- University of Colorado, Denver
- Recruiting in
- Aurora
- Registry record
- NCT06778135 · updated
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Boston Scientific Corporation
- Recruiting in
- Aurora · Grand Junction
- Registry record
- NCT02071134 · updated
SAD Study in Patients With Parkinson's Disease and Motor Fluctuations
- Phase 1
- Ages 40 to 80
- All sexes
- Sponsor
- Serina Therapeutics
- Recruiting in
- Englewood
- Registry record
- NCT07422675 · updated
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Denver · Grand Junction
- Registry record
- NCT06966700 · updated
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Aurora · Colorado Springs · Greeley · and 1 more U.S. location
- Registry record
- NCT06623422 · updated
Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in Colorado on ClinicalTrials.gov.
Epilepsy: recently updated in Colorado
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- Rapport Therapeutics Inc.
- Recruiting in
- Colorado Springs
- Registry record
- NCT07594119 · updated
Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in Colorado on ClinicalTrials.gov.
Migraine: recently updated in Colorado
Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Phase 4
- Ages 18 to 70
- All sexes
- Sponsor
- Mayo Clinic
- Recruiting in
- Aurora
- Registry record
- NCT06972056 · updated
Study of EVO756 in Adults With Migraine
- Phase 2
- Ages 18 to 64
- All sexes
- Sponsor
- Evommune, Inc.
- Recruiting in
- Denver
- Registry record
- NCT07616128 · updated
A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- TriGemX Bio, Inc.
- Recruiting in
- Aurora
- Registry record
- NCT07816367 · updated
Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Colorado on ClinicalTrials.gov.
Ask about studies in Colorado
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
CNS Clinical Research does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections